AI-enabled precision medicine for metabolic syndrome


MultiOmic Health is a next-generation AI-enabled precision medicine venture focusing on metabolic syndrome conditions — cardiovascular disease, diabetes, NAFLD/NASH and obesity


MultiOmic develops machine learning-enhanced systems biology models and composite biomarkers, validated and sharpened with targeted preclinical in vitro and in vivo experiments. These models and biomarkers are based on data from directly-managed observational clinical studies that deeply profile patients using multiple omics technologies, supplemented by datasets provided by strategic partners. MultiOmic uses its technology platform to originate new therapeutic and diagnostic R&D programmes for subsequent co-development and global commercialization with multinational biopharma and diagnostic companies